Aspirin DL-lysine
| Code | Size | Price |
|---|
| TAR-T20458-1g | 1g | £436.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Aspirin DL-lysine is a non-steroidal anti-inflammatory drug. It also may inhibit cancer growth. Aspirin DL-lysine is a water-soluble, injectable aspirin derivative.
CAS:
62952-06-1
Formula:
C15H22N2O6
Molecular Weight:
326.349
Purity:
0.98
SMILES:
NCCCCC(N)C(O)=O.CC(=O)Oc1ccccc1C(O)=O
References
1. Yasu T, Oshima S, Imanishi M, Nonogi H, Haze K, Kuramochi M, Omae T, Hayashi Y, Yamamoto S. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. Am J Cardiol. 1993 May 15;71(13):1164-8. PubMed PMID: 8480641.
2. Sakakibara H, Tsuda M, Suzuki M, Handa M, Saga T, Umeda H, Suetsugu S, Konishi Y. [A new method of diagnosis of aspirin-induced asthma by inhalation test with water-soluble aspirin (aspirin DL-lysine, Venopirin]. Nihon Kyobu Shikkan Gakkai Zasshi. 1988 Mar;26(3):275-83. Japanese. PubMed PMID: 3148054.
3. Whittem T, Freeman DA, Parton K, Hanlon DW. The pharmacokinetics of salicylate in dairy cattle are not altered by simultaneous intravenous ceftiofur sodium and DL-lysine-acetyl salicylate (aspirin). J Vet Pharmacol Ther. 1996 Apr;19(2):104-8. PubMed PMID: 8735416.
4. Nishimura S, Liang RF, Kawabata A, Arai T, Mizuno H, Sakata T, Maruyama S, Tajima M, Sato S. [Effects of aspirin DL-lysine on bone wound healing and bone growth in rats]. Meikai Daigaku Shigaku Zasshi. 1988;17(3):376-84. Japanese. PubMed PMID: 3271922.